Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice ; volume:5 ; number:1 ; day:20 ; month:6 ; year:2017 ; pages:1-11 ; date:12.2017
Journal for ImmunoTherapy of Cancer ; 5, Heft 1 (20.6.2017), 1-11, 12.2017
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Jing, Weiqing
- Beteiligte Personen und Organisationen
-
Gershan, Jill A.
Blitzer, Grace C.
Palen, Katie
Weber, James
McOlash, Laura
Riese, Matthew
Johnson, Bryon D.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-017-0256-z
- URN
-
urn:nbn:de:1111-2017090610010
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jing, Weiqing
- Gershan, Jill A.
- Blitzer, Grace C.
- Palen, Katie
- Weber, James
- McOlash, Laura
- Riese, Matthew
- Johnson, Bryon D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
Detection of myeloma cell-derived microvesicles: a tool to monitor multiple myeloma load
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
Allogeneic stem cell transplantation in multiple myeloma
Contact of myeloma cells induces a characteristic transcriptome signature in skeletal precursor cells-implications for myeloma bone disease
Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells
Natural killer cells efficiently target multiple myeloma clonogenic tumor cells
Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
CIK Cells and HDAC Inhibitors in Multiple Myeloma
CAR-T cells in multiple myeloma: current status
Accelerated single cell seeding in relapsed multiple myeloma
Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
Detection of myeloma cell-derived microvesicles: a tool to monitor multiple myeloma load
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
Allogeneic stem cell transplantation in multiple myeloma
Contact of myeloma cells induces a characteristic transcriptome signature in skeletal precursor cells-implications for myeloma bone disease
Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells
Natural killer cells efficiently target multiple myeloma clonogenic tumor cells
Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
CIK Cells and HDAC Inhibitors in Multiple Myeloma
CAR-T cells in multiple myeloma: current status
Accelerated single cell seeding in relapsed multiple myeloma
Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
Detection of myeloma cell-derived microvesicles: a tool to monitor multiple myeloma load
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
Allogeneic stem cell transplantation in multiple myeloma
Contact of myeloma cells induces a characteristic transcriptome signature in skeletal precursor cells-implications for myeloma bone disease
Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells
Natural killer cells efficiently target multiple myeloma clonogenic tumor cells
Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
CIK Cells and HDAC Inhibitors in Multiple Myeloma
CAR-T cells in multiple myeloma: current status